Quick View
| Metric | Current Period | Prior-year Period | YoY |
|---|---|---|---|
| Revenue | ¥52.7B | ¥57.8B | −8.7% |
| Operating Income | ¥9.1B | ¥11.5B | −21.5% |
| Ordinary Income | ¥9.4B | ¥11.5B | −18.9% |
| Net Income | ¥6.5B | ¥8.0B | −19.6% |
| ROE | 6.0% | 7.6% | - |
Executive Summary
In FY2026 Q3, consolidated results were Revenue ¥52.7B (YoY -¥5.1B, -8.7%), Operating Income ¥9.1B (YoY -¥2.4B, -21.5%), Ordinary Income ¥9.4B (YoY -¥2.1B, -18.9%), and Net Income attributable to owners of the parent ¥6.5B (YoY -¥1.5B, -19.6%). Gross margin held flat YoY at 46.3%, but Operating margin declined to 17.2% due to lower sales and a relatively higher SG&A burden. The full-year forecast assumes a recovery in sales in the second half, with Revenue ¥83.2B (YoY +5.6%), Operating Income ¥17.0B (YoY +3.7%), Ordinary Income ¥17.3B (YoY +0.6%), and Net Income ¥11.9B.
Key Financial Metrics
[Profitability] ROE 5.8% (down from about 6.5% in the prior-year period), Operating margin 17.2% (down -2.7pt from 19.9% in the prior-year period), Net margin 11.9% (down -1.6pt from 13.5%). The main driver of Operating margin decline was the relative increase in SG&A versus lower sales; the SG&A ratio deteriorated to 29.1%, up +2.6pt from 26.5% in the prior-year period. Return on Assets is 5.2%. ROE is explained by DuPont decomposition as Net margin 11.9% × Asset turnover 0.436 × Financial leverage 1.12x; YoY deterioration is mainly due to lower net margin and lower asset turnover. [Cash Quality] Cash and deposits of ¥28.8B account for 23.8% of total assets, covering short-term liabilities of ¥9.5B by 3.0x, ensuring ample liquidity. Accounts receivable decreased by ¥7.1B YoY to ¥11.8B, indicating working capital compression due to lower sales. [Investment Efficiency] Asset turnover of 0.436x (down from 0.479 in the prior-year period) was mainly driven by lower sales. [Financial Soundness] Equity Ratio 89.6% (improved +1.9pt from 87.7% in the prior-year period), Current ratio 833.2%, and Debt-to-equity ratio 0.12x, indicating a very robust capital structure. Interest-bearing debt is limited, with low interest burden risk.
Cash Flow Analysis
As the quarterly cash flow statement is not disclosed, we analyze funding trends from changes in the balance sheet. Cash and deposits increased by ¥0.8B from ¥28.0B in the prior-year period to ¥28.8B, suggesting profit generation from operating activities contributed to cash accumulation. In working capital, accounts receivable declined significantly by -37.4% YoY, implying improved cash efficiency driven by receivables compression alongside lower sales and better collection efficiency. Meanwhile, inventories were ¥32.3B, essentially flat from ¥32.0B in the prior-year period, indicating stable ongoing manufacturing activity. Trade payables were ¥4.9B, nearly unchanged from ¥5.0B in the prior-year period, suggesting stable supplier payment terms. Total current liabilities were ¥9.5B, down -¥1.8B from ¥11.3B in the prior-year period, reflecting progress in reducing short-term debt. With Cash and deposits of ¥28.8B and short-term liabilities of ¥9.5B, the coverage ratio is 3.0x, indicating very ample short-term liquidity and minimal funding risk. Net assets increased by ¥2.7B from ¥105.7B in the prior-year period to ¥108.4B, with retained earnings accumulation contributing to the expansion of shareholders’ equity.
Quality of Earnings
Against Ordinary Income of ¥9.4B, Operating Income was ¥9.1B, with a small positive non-operating balance of ¥0.3B. While details of non-operating income are not disclosed, they likely include interest and dividend income and foreign exchange gains. Non-operating income is limited to about 0.6% of Revenue, with core profitability derived from Operating Income. The Ordinary Income margin is 17.8%, improving +0.6pt from the Operating margin of 17.2%, but the contribution from non-operating income is limited. Net Income of ¥6.5B reflects taxes and other items deducted from Ordinary Income of ¥9.4B, implying an effective tax rate of approximately 30.4%, a standard level. Although the cash flow statement is not disclosed and thus an OCF-to-net income comparison is not feasible, the significant decrease in accounts receivable and increase in cash and deposits suggest generally sound cash conversion of earnings. From an accruals perspective, the decline in accounts receivable indicates prudent cash collection relative to profit recognition, implying limited accrual risk.
Risk Factors
There is a revenue decline risk due to weak sales demand. Cumulative Q3 Revenue decreased -8.7% YoY, close to double-digit decline, and achieving the full-year YoY +5.6% forecast presumes a significant recovery in sales in the remaining period. If demand uncertainty persists, there is a risk of downward revision. Fixed SG&A costs are a heavy burden; in a sales downturn, the SG&A ratio rose from 26.5% to 29.1% (+2.6pt), implying a structural risk of further margin compression if sales recovery is delayed. As a manufacturer, the Company is exposed to raw material prices and foreign exchange fluctuations. While the gross margin of 46.3% has been maintained, higher procurement costs or adverse FX movements could pressure margins.
Industry Benchmark (Reference; Our Research)
[Position within Industry] (Reference information; Our research) Compared with the Manufacturing sector median in 2025 Q3, profitability is high: the Operating margin of 17.2% is well above the sector median of 7.3%, placing the Company in the upper tier, and the Net margin of 11.9% exceeds the sector median of 5.4% by +6.5pt. ROE 5.8% is slightly above the sector median of 4.9%. Return on Assets of 5.2% is also +1.9pt above the sector median of 3.3%, surpassing the industry average in both asset efficiency and profitability. In soundness, the Equity Ratio of 89.6% is far above the sector median of 63.9%, reflecting an exceptionally strong capital structure within the sector. The Current ratio of 833.2% is roughly three times the sector median of 267%, representing top-tier short-term liquidity. The Net Debt/EBITDA multiple is effectively negative (net cash), significantly below the sector median of -1.11, indicating a financial profile close to debt-free. In growth, Revenue growth of -8.7% is below the sector median of +2.8%; while the industry shows slight top-line growth, the Company is in a revenue contraction phase and ranks lower on growth. Overall, the Company exhibits a financial profile of high profitability, high soundness, and low growth; within the sector it has advantages in financial base and margins, while recovery of top-line growth remains the key challenge. Note: Industry: Manufacturing (N=65 companies), Comparison period: 2025 Q3, Source: our compilation
Key Takeaways from the Results
While top-tier Operating margin of 17.2% and Net margin of 11.9% demonstrate strong profitability, margins and sales are simultaneously declining YoY, making sales recovery in the second half critical to achieving the full-year guidance. The significant YoY decrease of -37.4% in accounts receivable suggests improved working capital efficiency; however, the causal link with lower sales warrants scrutiny, including potential changes in collection terms or sales mix, and should be monitored. The Equity Ratio of 89.6%, Current ratio of 833.2%, and a financial structure close to net cash minimize short-term credit and liquidity risks. The dividend with a Payout Ratio of 52.5% (year-end ¥28) is supported by ¥28.8B in cash and deposits and a low-debt structure, indicating high sustainability and ample capacity for shareholder returns.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmark is reference information compiled by us based on publicly available financial statements. Investment decisions are your responsibility; please consult a professional as needed before making any decisions.
AI Financial Analysis
Executive Summary
FY2026 Q3 earnings were weaker year on year, with the decline driven primarily by lower sales and substantially weaker operating leverage despite a modest improvement in gross margin. Revenue for the nine-month cumulative period was ¥5.274bn, down 8.7% year on year. Operating income declined 21.5% to ¥906m. Ordinary income fell 18.9% to ¥936m, while profit attributable to owners declined 19.6% to ¥628m. The gross margin improved 53bp year on year to 46.3%, from 45.7%, indicating that gross profitability remained resilient. However, the operating margin compressed 278bp to 17.2%, from 20.0%, because SG&A expenses increased 3.1% to ¥1.534bn while revenue fell. Net margin declined 161bp to 11.9%, from 13.5%, but remains above the 10% level generally associated with strong profitability. Non-operating income of ¥37m was modest at 0.7% of revenue and therefore did not materially affect earnings quality. Interest income of ¥13m and dividend income of ¥5m were the principal identified financial-income items. The effective tax rate was 30.4%, producing a tax burden of 0.671, slightly below a normalized 0.70 benchmark but not indicative of an unusually severe tax burden. Annualized ROE was 7.7%, below the 8% caution threshold and reflecting lower profitability rather than financial leverage. The capital structure remains highly conservative, with a current ratio of 833.2% and debt-to-equity of only 0.12x. Receivables declined sharply, supporting liquidity, although reported working-capital efficiency alerts indicate lengthy collection and inventory-conversion cycles. Full-year guidance requires a marked acceleration in Q4, particularly in operating profit, making execution against the forecast the central near-term issue. The company forecasts FY2026 revenue of ¥8.320bn, operating income of ¥1.698bn and profit attributable to owners of ¥1.192bn, implying recovery versus the current nine-month trend. No investment recommendation is provided.
Profitability Analysis
The supplied annualized DuPont analysis decomposes ROE of 7.7% into a 11.9% net profit margin, 0.582x asset turnover and 1.12x financial leverage. The low financial-leverage factor confirms that returns are generated principally from operating profitability and asset utilization rather than debt financing. The largest adverse change is profitability at the operating level: revenue fell 8.7%, whereas SG&A rose 3.1%, causing operating income to fall 21.5%. Gross profit fell 7.6% to ¥2.440bn, less sharply than revenue, and gross margin rose to 46.3% from 45.7%. This gross-margin expansion suggests pricing, product mix, procurement, or production economics partly offset lower sales volume. In contrast, SG&A represented 29.1% of revenue versus 25.8% a year earlier, a 332bp increase, more than offsetting the gross-margin gain. Consequently, operating margin compressed to 17.2% from 20.0%. The annualized asset turnover of 0.582x is moderate for a manufacturer with a substantial fixed-asset base, including ¥3.180bn of PPE, equal to 26.3% of total assets. Annualized ROA is approximately 6.9%, calculated using annualized nine-month profit attributable to owners of about ¥837m and average total assets of approximately ¥12.074bn; this is positive but below the 10% high-return benchmark. The interest burden of 1.034 reflects net financial income rather than interest-cost pressure, consistent with the cash-rich balance sheet. The tax burden of 0.671 was the only negative contribution within the five-factor bridge, but its impact was limited compared with the decline in operating margin. The profit decline appears operational rather than driven by major non-recurring or financing items, as the gap between operating income and profit before tax was only ¥31m.
Growth Assessment
Nine-month revenue declined ¥502m year on year to ¥5.274bn, indicating that demand, shipment timing, or customer capital-spending conditions remained unfavorable through Q3. Operating income fell by ¥247m, materially faster than sales, demonstrating negative operating leverage from the fixed or semi-fixed SG&A base. Profit attributable to owners decreased by ¥153m to ¥628m, broadly tracking the operating-income decline. The improved gross margin mitigated the earnings impact of reduced sales, but it was insufficient to absorb the higher SG&A-to-sales ratio. The full-year sales forecast of ¥8.320bn implies a nine-month progress rate of 63.4%, 11.6 percentage points below the standard 75% Q3 pace. The operating-income forecast progress rate is 53.4%, 21.6 percentage points below the standard pace. Profit attributable to owners has reached 52.7% of the FY forecast, also 22.3 percentage points below the standard Q3 pace. To achieve guidance, Q4 revenue must reach approximately ¥3.046bn and Q4 operating income approximately ¥792m. This would require a Q4 operating margin of roughly 26.0%, well above the 17.2% achieved in the first nine months. The implied Q4 profit attributable to owners of approximately ¥564m would also approach 90% of nine-month cumulative profit. Guidance therefore embeds a substantial final-quarter improvement in revenue conversion and profitability. The key evidence required for forecast credibility is a recovery in order execution, better fixed-cost absorption, and retention of the improved gross margin.
Financial Health
Financial health is strong. Current assets of ¥7.895bn exceeded current liabilities of ¥947m by ¥6.947bn, producing working capital of ¥6.947bn and a current ratio of 833.2%. The quick ratio of 746.8% demonstrates that liquidity does not depend on inventory liquidation. Cash and deposits were ¥2.875bn, representing 23.8% of total assets and more than three times current liabilities. Total liabilities were only ¥1.252bn, equivalent to 10.4% of total assets, against total equity of ¥10.840bn. Debt-to-equity of 0.12x is far below the 2.0x warning threshold, leaving substantial balance-sheet capacity. There is no maturity-mismatch concern apparent from current assets materially exceeding current liabilities. Net defined benefit liability was ¥244m, equivalent to 19.5% of total liabilities, and should remain a balance-sheet item to monitor. Provision for bonuses was ¥67m, provision for loss on orders was ¥23m, and product-warranty provision was ¥69m. Trade accounts receivable declined 37.4% year on year to ¥1.177bn, which improved reported balance-sheet liquidity. Electronically recorded monetary claims, however, increased to ¥534m from ¥443m, and the broader trade-claim balance remains relevant to collection efficiency. The reported HIGH_RECEIVABLE_DAYS alert, with DSO of 61 days against a 60-day threshold, indicates slower-than-desired cash collection for a manufacturer; the impact is a longer cash commitment and potential sensitivity to customer payment timing. The reported HIGH_INVENTORY_DAYS alert of 292 days indicates a particularly extended inventory-conversion cycle, heightening risks of working-capital absorption, demand-forecast error, and inventory obsolescence. A separate HIGH_INVENTORY_DAYS alert of 79 days also exceeds the 60-day manufacturing benchmark; irrespective of the measurement basis, both alerts point to inventory efficiency requiring close monitoring. The reported LONG_CCC alert of 324 days, versus a 120-day threshold, combines collection and inventory-cycle pressure and can constrain cash conversion even with a strong absolute liquidity position.
Notable B/S Changes
Accounts receivable: -¥702m (-37.4%) to ¥1.177bn - supports balance-sheet liquidity, although reported DSO of 61 days and elevated cash-conversion-cycle alerts indicate that collection efficiency remains a key operating focus.
Cash Flow Quality
The reported working-capital alerts are the primary indicators for cash-conversion quality. DSO of 61 days is above the stated 60-day warning threshold, indicating collection timing that is marginally slower than the preferred range. The 292-day inventory-days alert signals a potentially substantial amount of capital tied up in the production and inventory cycle. The separate 79-day inventory-days alert also exceeds the 60-day benchmark and reinforces the need to monitor stock efficiency across inventory definitions. The reported cash conversion cycle of 324 days is well above the 120-day warning threshold and is the most material operating-cash-cycle concern. For a manufacturer, such a long cycle can increase sensitivity to order delays, customer acceptance timing, and changes in production schedules. Finished goods reported on the balance sheet were ¥819m, while raw materials and work in process disclosed in the manufacturing detail were ¥1.500bn and ¥707m, respectively; inventory management and conversion into sales are therefore important determinants of future cash realization. The product-warranty provision of ¥69m equals approximately 1.3% of nine-month revenue, a manageable level but one that should be monitored alongside production volumes and quality costs. The decline in trade accounts receivable to ¥1.177bn provides a favorable counterpoint to the DSO alert, but it does not eliminate the need to track the broader receivables and inventory cycle. Cash conversion should be assessed principally through subsequent changes in trade claims, inventory balances, order fulfillment, and customer collections.
Dividend Sustainability
The company forecasts an FY2026 dividend per share of ¥29.0. Against forecast EPS of ¥119.7, the implied dividend payout ratio is approximately 24.2%, well below the 60% sustainability benchmark. Based on average shares outstanding of 9.963m, the implied aggregate annual dividend is approximately ¥289m. This is modest relative to forecast profit attributable to owners of ¥1.192bn. The balance sheet provides substantial support for distributions, with cash and deposits of ¥2.875bn and total equity of ¥10.840bn. The Q2 dividend per share was ¥0, indicating that the expected annual distribution is likely concentrated in a later payment rather than split evenly through the year. The large treasury-share balance of 1.800m shares is relevant to per-share capital allocation, although no current-period repurchase activity is identified. The principal factor affecting dividend visibility is achievement of the full-year earnings forecast, given the low nine-month progress rate against that forecast. On the stated FY dividend plan and earnings forecast, the dividend appears conservatively covered by earnings.
Risk Assessment
Business risks include Demand and order-execution risk: nine-month revenue declined 8.7%, while FY guidance requires Q4 revenue of approximately ¥3.046bn, or 36.6% of full-year forecast sales., Operating-leverage risk: SG&A increased 3.1% while sales fell, causing a 278bp operating-margin contraction to 17.2%., Manufacturing inventory risk: reported inventory-day alerts of 292 days and 79 days both exceed their applicable warning thresholds, indicating risks around production planning, stock turnover, obsolescence, and working-capital intensity., Collection-cycle risk: reported DSO of 61 days exceeds the 60-day warning threshold, exposing cash conversion to customer payment timing., Product-quality and execution risk: the ¥69m product-warranty provision, equal to approximately 1.3% of nine-month revenue, remains manageable but warrants monitoring as production and shipment volumes evolve., Foreign-exchange risk: foreign-exchange losses of ¥2m were immaterial in the nine-month period, but export-oriented manufacturing demand and currency movements can affect competitiveness and reported earnings..
Financial risks include Forecast-delivery risk is elevated: operating-income progress is 53.4% against a standard 75% Q3 pace, requiring approximately ¥792m of Q4 operating income., Cash-conversion-cycle risk is elevated: the reported CCC of 324 days exceeds the 120-day warning benchmark by a wide margin., Comprehensive income declined 35.2% year on year to ¥540m, more sharply than net income, reflecting adverse movements in other comprehensive income including foreign-currency translation effects., Defined-benefit obligation risk: net defined benefit liability of ¥244m is meaningful relative to total liabilities, though modest relative to equity..
Key concerns include Highest priority: whether the company can generate the implied Q4 operating margin of approximately 26.0% needed to meet FY guidance., High priority: whether elevated inventory and cash-conversion metrics normalize without margin-sacrificing discounting or production adjustments., Medium priority: whether the SG&A base can be contained or leveraged as revenue recovers., Mitigant: current ratio of 833.2%, quick ratio of 746.8%, and debt-to-equity of 0.12x materially limit near-term balance-sheet and refinancing risk..
Investment Implications
Key takeaways include Gross-margin resilience is positive, with gross margin improving 53bp to 46.3% despite an 8.7% sales decline., The principal earnings weakness is below gross profit: SG&A growth exceeded revenue growth, reducing operating margin by 278bp., The company retains an exceptionally strong liquidity profile, with ¥6.947bn of working capital and only ¥1.252bn of total liabilities., Working-capital efficiency is the key operational watchpoint, given reported DSO of 61 days, inventory-day alerts of 292 days and 79 days, and CCC of 324 days., FY guidance assumes a pronounced Q4 recovery, especially in profitability, and therefore represents a demanding execution threshold., The forecast ¥29.0 dividend implies a conservative 24.2% dividend payout ratio based on forecast EPS..
Metrics to watch include Quarterly revenue recovery and order execution relative to the implied ¥3.046bn Q4 sales requirement, Operating margin versus the approximately 26.0% Q4 margin implied by FY operating-income guidance, SG&A expense growth relative to revenue growth, Gross-margin durability above the Q3 cumulative 46.3% level, DSO, inventory days, and cash conversion cycle, Trade receivables, electronic monetary claims, raw-materials inventory, work in process, and finished-goods balances, Warranty provision relative to revenue and production volume, Comprehensive-income volatility from foreign-currency translation and securities valuation movements.
Regarding relative positioning, Profitability remains strong in absolute terms, with a 17.2% operating margin and 11.9% net margin, while balance-sheet conservatism is materially stronger than typical leveraged industrial peers. However, annualized ROE of 7.7% is below the 8% caution benchmark, and the company currently faces weaker operating momentum and less efficient reported working-capital conversion than preferred manufacturing benchmarks.